Emphasizing the vitality of genomics related research in the area of infectious diseases

Scientific Research and Essays

Volumn 3, Issue 4, 2008, Pages 125-131

  Misaki, Wayengera ^a   Byarugaba, Wilson ^a  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

Genomics; HIV AIDS; Infectious diseases; Malaria; Tuberculosis

Indexed keywords

EID: 69049094776     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. An P, Martin MP, Nelson GW, Carrington M, Smith MW, Gong K, Vlahov D, O'Brien S, Winkler, C A (2000a). Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS 2000. 14(21): 17-22.
2. An P, Martin MP, Nelson GW, Carrington M, Smith MW, Gong K, Vlahov D, O'Brien S, Winkler CA (2000b). Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS 2000; 14(21): 17-22.
3. An P, Nelson GW, Wang L, Donfield S, Goedert JJ, Phair J, Vlahov, D (2002). Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA. 99(1000): 2-7.
4. Almond NK, Kent M, Cranage E, Rud B, Clarke E, Stott J. (1995). Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345: 1342-1344
5. Anderson, T.J. (2004). Mapping drug resistance genes in Plasmodium falciparum by genome-wide association. Curr Drug Targets Infect Disord. 4: 65-78.
6. Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM (1995). Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Sci. 267: 1820-1825.
7. Blaak H, van't Wout AB, Brouwer M, Cornelissen M, Kootstra NA, Albrecht-van Lent N, Keet RP, Goudsmit J, Coutinho RA, Schuitemaker H (1998) Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to nonsynsytium- inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples. J. Virol., 72: 218-224.
8. Blower SM, McLean AR (1994). Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Sci. 265: 1451-1454.
9. Bolognesi DP (1994). Not yet, it is too early to consider use of a liveattenuated virus vaccine against HIV-1. J. NIH Research. 6: 55-62.
10. Bowman S, Lawson D, Basham D, Brown D, Chillingworth T, Churcher CM, Craig A, Davies RM, Devlin K, Feltwell T (1999) The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum. Nature 400: 532-538.
11. Breman JG (2001).The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 64: 1-11
12. Carmichael A, Jin X, Sissons P (1996). Analysis of the human envspecific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: Low prevalence of broadly cross-reactive env-specific CTL. J. Virol. 70: 8468-8476.
13. Carrington M, Nelson NW, Martin MP, Kissner T, Vlahov D, Goedert JJ (1999). HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283(17): 48-52.
14. Casanova JL, Romero P, Widmann C, Kourilsky P, Maryanski JL (1991). T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med. JEM. 174: 1371-1383.
15. Cease KB, Berzofsky JA (1994). Toward a vaccine for AIDS: The emergence of immunobiology-based vaccine development. Ann Rev Immunol. 12: 923-989.
16. Chen Q, Schlichtherle M, Wahlgren M (2000). Molecular Aspects of Severe Malaria. Clin Microbiol Rev. July. 13(3): 439-450.
17. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF (1997). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387: 183-187.
18. Clerici M, Levin JM, Kessler HA, Harris A, Berzofsky JA, Landay AL, Shearer GM (1994). HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 271: 42-46.
19. Cohen J (1997) Weakened SIV vaccine still kills. Sci. 278: 24-25.
20. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.[An erratum appears in Nature 396,190] Nature. 393: 537-544.
21. Cowman AF (2001) Functional analysis of drug resistance in Plasmodium falciparum in the post-genomic era. Int. J. Parasitol. 31: 871-878.
22. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers, RC (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Sci. 258: 1938-1941.
23. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ (1996). Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study Sci. 273: 1856-62.
24. Desrosiers RC (1994).Yes it is time to consider use of a live-attenuated virus vaccine against HIV-1. J NIH Res. 6: 54-59.
25. Dorak M, Tang T, Penman-Aguilar A, Westfall A, Zulu I, Lobashevsky EN, Kancheya M, Schaen, S, Allen R. Kaslow (2004). Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. Lancet. 363:2137-9.
26. Drazen JM, Phimister EG. (2007). Publishing Genomewide Association Studies. NEJM July 18. 357(5):496.
27. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF (2007). Whole-Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis NEJM AUG 23rd. 357(8):775-788.
28. Duraisingh, MT, Roper C, Walliker D, Warhurst DC (2000). Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol. 36: 955-961.
29. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, French ALT (2000). Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Sci. 287: 2274-7.
30. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT (2000). Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell. 6: 861-871.
31. Flori L Sawadogo S, Esnault C, Delahaye NF, Fumoux F, Rihet P (2003). Linkage of mild malaria to the major histocompatibility complex in families living in Burkina Faso. Hum Mol Genet Feb 15. 12(4): 375-378.
32. Gallup JL, Sachs JD (2001).The economic burden of malaria. Am. J. Trop. Med. Hyg. 64: 85-96.
33. Galvani AP, Slatkin M (2003). Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc. Natl. Acad Sci USA. 100:15276-9.
34. Gardner MJ, Tettelin H, Carucci DJ, Cummings LM, Aravind L., Koonin EV, Shallom S, Mason T, Yu K, Fujii C (1998) Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Sci 282: 1126-1132.
35. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ (2005). The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Sci. 307(14): 34-40.
36. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher M, Mangano A, Bologna R, Ahuja SS, Dolan MJ, Ahuja SK (2002). HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Epub 2002 Oct 8. Proc Natl Acad Sci USA.15: 99(21): 13795-800.
37. Goudsmit J, Back NKT, Nara PL. (1991). Genomic diversity and antigenic variation of HIV-1: Links between pathogenesis, epidemiology and vaccine development. FASEB J. 5: 2427-2436.
38. Graham BS, Wright PF (1995). Candidate AIDS vaccines. N. Engl. J Med. 333: 1331-1339.
39. Greenwood B, Mutabingwa T (2002). Malaria in 2002. Nature 415: 670-672.
40. Haas DW (2006). Human genetic variability and HIV treatment response. Curr HIV/AIDS Rep. 3(5): 3-8.
41. Haynes BF (1996). HIV vaccines: Where we are and where we are going. Lancet. 348: 933-937.
42. Hayton K, Su X.-Z. (2004). Genetic and biochemical aspects of drug resistance in malaria parasites. Curr. Drug. Targets. Infect. Disord. 4: 1-10.
43. HIV Sequence database (2007). HIV-1, HIV-2 and SIV ENV proteins. http://www.hiv.lanl.gov/content/hiv-db/ALIGN_CURRENT/ALIGNINDEX.html Accessed 18th AUG 2007.
44. Hoffman, SL, Bancroft WH, Gottlieb M, James SL, Burroughs, EC, Stephenson JR, Morgan, M. J (1997) Funding for malaria genome sequencing. Nature. 387: 647.
45. Hu DJ, Dondero TJ, Rayfield MA, George JR, Schochetman G, Jaffe HW, Luo CC (1996). The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA, 275: 210-216.
46. International Human Genome Sequencing Consortium (2004). Finishing the euchromatic sequence of the human genome Nature 21 October. 431: 931-945.
47. Johnson RP, Glickman RL, Yang JQ, Kaur A, Dion JT, Mulligan MJ, Desrosiers RC (1997). Induction of vigorous cytotoxic T lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol. 71: 7711-7718.
48. Johnson RP, Kalams S, (1998). The Science of HIV Vaccine Development. In HIV InSite Knowledge Base Chapter May, http://hivinsite.ucsf.edu/InSite?page=kb-00&doc=kb-02-01-06 Accessed 18th AUG 2007.
49. Karacki M, Martin MP, Phair J, Deschenes RMJ, Nelson GR (2001). Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344(16): 68-75.
50. Kaslow RA, Carrington M, Apple Park RL, Muñoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, Mann DL (1996). Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med. 2(40): 5-11.
51. Keet IPM, Tang J, Klein MR, LeBlanc R, Enger C, Rivers C, Apple RJ (1999). Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J. Infect. Dis. 180:299-309.
52. Liu G, Carrington M, Kaslow RA, Gao X, Rinaldo CR, Jacobson LP, Margolick JB (2003). Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection. J Infect. Dis. 187(140): 4-10.
53. MacDonald KS, Embree J, Njenga S, Nagelkerke NJ, Ngatia I, Mohammed Z, Barber BH (1998). Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis, 177: 551-556.
54. Mann DL (2007). MicroRNAs and the Failing Heart NEJM July 7th. 356(22): 2346-2347.
55. Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW (1998). Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science, 282: 1907-1911.
56. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S (2002). Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 31: 429-34.
57. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi SBC, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R, Fusi ML, Tofani N, Biasin M, Villa ML, Mazzotta F, Clerici M (1997). HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3: 1250-1257.
58. McLean AR, Blower SM (1993). Imperfect vaccines and herd immunity to HIV. Proc. R. Soc. Lond B. 253: 9-13.
59. Michael NL, Louie LG, Rohrbaugh AL, Dayhoff DE, Wang CE, Sheppard HW. (1997). The role of CCR5 and CCR2 polymorphisms HIV-1 transmission and disease progression. Nat Med. 3: 1160-1162.
60. Michel SF, Libert BJ, Doranz, Joseph R, Corinne L, Claire-Michèle F, Sentob S, Claudine L, Jacqueline C (1996). Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382: 722-725.
61. Misaki W (2007). A Recombinant Lactobacillus Strain Expressing Genes. Coding for Restriction Enzymes Cleaving the HIV Genomes for Use as a Live Microbicide Strategy against Heterosexual Transmission of HIVAJB AUG 6th, 6(15); 1750-1756.
62. Moalem S, Prince J. (2007) Survival of the Sickest: A Medical Maverick Discovers Why We Need Disease. In Survival of the Sickest: A Medical Maverick Discovers Why We Need Disease. New York, William Morrow,.Book review. NEJM July 26th; 357(4): 427.
63. Modi WS, Goedert JJ, Strathdee S, Buchbinder, Detels R, Donfield S, O'Brien SJ, Winkler C (2003). MCP-1-MCP-3-eotaxin gene cluster influences HIV-1 transmission. AIDS. 17: 2357-2365.
64. National Centre for Biotechnology Information (NCBI) (2007). 540 Complete Microbial Genomes selected: [A] - 44, [B] - 496 Accessed 21st July 2007. http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi
65. Orrell RW (2007). Understanding the Causes of Amyotrophic Lateral Sclerosis NEJM 2007 Aug 23rd. 357(8):822-823.
66. Peterson DS, Walliker D, Wellems TE (1988). Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. USA. 85: 9114-9118.
67. Paterson S, Wilson K., Pemberton JM (1998). Major histocompatibility complex variation associated with juvenile survival and parasite resistance in a large unmanaged ungulate population (Ovis aries L.) Proc. Natl. Acad. Sci. USA 95: 3714-3719.
68. Perelson AS, Neumann AU, Markowitz M, Leonard PM, Ho DD (1996). HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Sci. 271:1582-1586.
69. Pinto LA, Sullivan J, Berzofsky JA, Clerici M, Kessler HA, Landay AL, Shearer GM (1995). ENV-specific cytotoxic T lymphocyte respon-ses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96: 867-876.
70. Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA (2007). Clinical Outcomes of Breast Cancer in Carriers of BRCA1 and BRCA2 Mutations NEJM July 12th,357(2):115-123.
71. Robson M, Offit K. (2007). Management of an Inherited Predisposition to Breast Cancer NEJM July 12th. 357:154-162.
72. Robertson DL, Sharp PM, McCutchan FE, Hahn BH (1995). Recombination in HIV-1. Nature. 374: 124-126.
73. Obinson BA, Welch TL, Smith JD (2003). Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome. Molecular Microbiology March, 47(5):1265-1278.
74. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ (2007). Genomewide Association Analysis of Coronary Artery Disease NEJM Aug 2nd. 357(5):443-453.
75. The International Multiple Sclerosis Genetics Consortium. (2007) Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study NEJM AUG 30th. 357(9):851-862.
76. Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, Palsson S, (2007). A Genetic Risk Factor for Periodic Limb Movements in Sleep NEJM AUG 16th. 357(7):639-647.
77. Wheeler PR, Ratledge C (1994). In Tuberculosis: Pathogenesis, Protection, and Control (ed. Bloom, B. R.) (Am. Soc. Microbiol., Washington DC) 353-385.
78. Saah AJ, Hoover DR, Weng S, Carrington M, Mellors J, Rinaldo CR, Mann D (1998). Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection: Multicenter AIDS Cohort Study. AIDS.12:2107-2113.
79. Schwarzer E, Alessio M, Ulliers D, Arese P (1998). Phagocytosis of the Malarial Pigment, Hemozoin, Impairs Expression of Major Histocompatibility. Complex Class II Antigen, CD54, and CD11c in Human Monocytes. Infect. Immun. 66(4): 1601-1606
80. Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, O'Brien TR, Vlahov D, Buchbinder S, Giorgi J, Rinaldo C, Donfield S, Willoughby A, O'Brien SJ, Smith MW (2000). Genetic restriction of HIV- 1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA. 97:19:97(26):14467-14472
81. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C (1998). Dating the origin of the CCR5- 32 AIDSresistance allele by the coalescence of haplotypes. Am J Hum Genet, 62: 1507-1515.
82. Smith JD, Subramanian G, Gamain B, Baruch DI, Miller LH (2000). Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Mol. Biochem. Parasitol. 110: 293-310.
83. Snider DEJ, Raviglione M, Kochi A (1994). In: Tuberculosis, Pathogenesis, Protection, and Control (ed. Bloom, B. R.) 2-11 (Am. Soc. Microbiol. Washington DC.
84. Su XZ, Wootton JC. (2004). Genetic mapping in the human malaria parasite Plasmodium falciparum. Mol. Microbiol. Sept. 53 (6): 1573-1582.
85. Tang J, Costello C, Keet IPM, Rivers C, Leblanc S, Karita E, Allen S, Kaslow RA. (1999). HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 15: 317-324.
86. Tang J, Shelton B, Makhatadze NJ, Zhang Y, Schaen M, Louie LG, Goedert JJ, Seaberg EC, Margolick JB, Mellors J Kaslow RA (2002a). Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression. J. Virol. 76(2): 662-672.
87. Tang J, Wilson CM, Meleth S, Myracle A, Lobashevsky E, Mulligan MJ, Douglas SD, Korber B, Vermund SH, Kaslow RA (2002b). Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS, 16:2275-2284.
88. Tang J, Wilson CM, Schaen M, Myracle A, Douglas SD, Kaslow RA. (2002c). CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy. AIDS Res. Hum. Retroviruses 18: 403-412.
89. UNAIDS. (2006) Report on the global HIV-AIDS epidemic July.
90. Valcke HS, Bernard NF, Bruneau J, Alary M, Tsoukas CM, Roger M (2004). APOBEC3G genetic variants and their influence on the progression to AIDS. J. Virol. 78: 11070-11076.
91. Walliker D, Quakyi IA, Wellems TE, McCutchan TF, Szarfman A, London WT, Corcoran LM, Burkot OR, Carter R (1987).Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236: 1661-1666.
92. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, Desrosiers RC (1996).Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70: 3724-3733.
93. Wyand MS, Manson KH, Lackner AA, Desrosiers RC et al. (1997). Resistance of neonatal monkeys to live attenuated strains of simian immunodeficiency virus. Nat Med. 3: 32-36.
94. Wootton, J.C., Feng, X., Ferdig, M.T., Cooper, R.A., Mu J, Baruch DI, et al., (2002). Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418: 320-323.
95. Wormser GP (2007). Discovery of New Infectious Diseases - Bartonella Species. NEJM July 7th; 356(23): 2346-2347.
96. Winkler C, Modi W, Smith MW, GW Nelson, X Wu, Carrington M, Dean M, Honio T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahoy D, Phair J, O'Brien SJ (1998). Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant: ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279(5349): 389-393.
97. Yates JRW, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT, the Genetic Factors in AMD Study Group (2007).Complement C3 Variant and the Risk of Age-Related Macular Degeneration NEJM, Aug 9th Volume 357(6): 553-561.